tiprankstipranks
Trending News
More News >
Pharvaris (PHVS)
NASDAQ:PHVS

Compare Pharvaris (PHVS) vs. Competitors

Compare
157 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharvaris
$27.81
$1.76B
-8.64
62.25%
8 Buy
1 Hold
0 Sell
Strong Buy
BioCryst
$6.70
$1.64B
-141.65
-12.07%
8 Buy
1 Hold
0 Sell
Strong Buy
Celldex
$25.17
$1.64B
-7.44
6.43%
8 Buy
0 Hold
1 Sell
Strong Buy
Viridian Therapeutics
$31.90
$3.17B
-9.03
65.28%
12 Buy
1 Hold
0 Sell
Strong Buy
Edgewise Therapeutics
$29.65
$3.06B
-18.80
5.14%
8 Buy
1 Hold
0 Sell
Strong Buy
Biohaven Ltd.
$11.39
$1.71B
-1.50
-69.80%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHVS
Pharvaris
27.81
10.28
58.64%
BCRX
BioCryst
6.70
-1.91
-22.18%
CLDX
Celldex
25.17
1.18
4.92%
VRDN
Viridian Therapeutics
31.90
12.66
65.80%
EWTX
Edgewise Therapeutics
29.65
-0.38
-1.27%
BHVN
Biohaven Ltd.
11.39
-27.75
-70.90%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts